MOLECULAR DOCKING STUDY OF QUINOLIN-4(1H)-ONE DERIVATIVES AS VEGFR-2 INHIBITORS FOR THE TREATMENT OF LUNG CANCER. FMHR [Internet]. 2025 Aug. 1 [cited 2026 Mar. 9];3(6):1-15. Available from: https://fmhr.net/index.php/fmhr/article/view/712